| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-07 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-07 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.26 |
1e-06 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.26 |
3e-06 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.26 |
5e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.25 |
1e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |